Chukwuonye Innocent Ijezie, Ogah Okechukwu Samuel, Anyabolu Ernest Ndukaife, Ohagwu Kenneth Arinze, Nwabuko Ogbonna Collins, Onwuchekwa Uwa, Chukwuonye Miracle Erinma, Obi Emmanuel Chukwuebuka, Oviasu Efosa
Division of Nephrology, Department of Internal Medicine, Federal Medical Centre, Umuahia, Abia State.
Division of Cardiology, Department of Internal Medicine, University College Hospital Ibadan, Oyo State.
Int J Nephrol Renovasc Dis. 2018 May 22;11:165-172. doi: 10.2147/IJNRD.S162230. eCollection 2018.
The aim of this study was to identify and discuss published population-based studies carried out in Nigeria that have information on the prevalence of chronic kidney disease (CKD) and have also used the Kidney Disease Outcomes Quality Initiative (KDOQI) practice guidelines in defining CKD, with emphasis on the performance of three estimating equations for glomerular filtration rate (GFR) - Modification of Diet in Renal Disease (MDRD), Cock-croft-Gault, and CKD epidemiology collaboration (CKD-EPI) creatinine equation.
A systematic literature search was carried out in Google, MEDLINE, PubMed, and AJOL database, with the aim of identifying relevant population-based studies with information on the prevalence of CKD in a location in Nigeria.
Seven cross-sectional population-based studies were identified. Two of the studies used the Cockcroft-Gault and observed a prevalence of 24.4% and 26%. Four of the studies used the MDRD and the prevalences observed were 12.3%, 14.2%, 2.5%, and 13.4%. One of the studies used the CKD-EPI equation and the prevalence was 11.4%. The male to female ratios of CKD prevalence in six studies were 1:1.9, 0.8:1, 1:1.6, 1:2, 1:1.8, 1:1.4, and the observed risk factors in the studies were old age, obesity, diabetes mellitus, hypertension, family history of hypertension, family history of renal disease, low-income occupation, use of traditional medication, low hemoglobin, and abdominal obesity.
The prevalence of CKD was high but variable in Nigeria, influenced by the equation used to estimate the GFR. MDRD and CKD-EPI results are agreeable. There is a need for more population-based studies, with emphasis on repeating the GFR estimation after 3 months in subjects with GFR <60 mL/min/1.7 m.
本研究的目的是识别并讨论在尼日利亚开展的已发表的基于人群的研究,这些研究包含慢性肾脏病(CKD)患病率的信息,并且在定义CKD时也采用了肾脏病预后质量倡议(KDOQI)实践指南,重点关注三种肾小球滤过率(GFR)估算方程的表现——肾脏病膳食改良(MDRD)方程、Cockcroft-Gault方程以及CKD流行病学协作组(CKD-EPI)肌酐方程。
在谷歌、MEDLINE、PubMed和AJOL数据库中进行了系统的文献检索,目的是识别在尼日利亚某地有关CKD患病率信息的相关基于人群的研究。
识别出七项基于人群的横断面研究。其中两项研究使用了Cockcroft-Gault方程,观察到的患病率分别为24.4%和26%。四项研究使用了MDRD方程,观察到的患病率分别为12.3%、14.2%、2.